Introduction to the Special Issue on Marketing Science and Health

Published Online:https://doi.org/10.1287/mksc.2020.1230

References

  • Barron L (2020) What we can learn from Singapore, Taiwan and Hong Kong about handling coronavirus. Time (March 13), https://time.com/5802293/coronavirus-covid19-singapore-hong-kong-taiwan/.Google Scholar
  • Batra R, Keller PA, Strecher VJ, eds. (2011) Leveraging Consumer Psychology for Effective Health Communications: The Obesity Challenge (M. E. Sharpe, Abingdon, UK).Google Scholar
  • Bowman D, Heilman CM, Seetharaman PB (2004) Determinants of product-use compliance behavior. J. Marketing Res. 41(3):324–338.CrossrefGoogle Scholar
  • Bublitz MG, Peracchio LA, Block LG (2010) Why did I eat that? Perspectives on food decision making and dietary restraint. J. Consumer Psychol. 20(3):239–258.CrossrefGoogle Scholar
  • Burns LR, ed. (2012) The Business of Healthcare Innovation (Cambridge University Press, Cambridge, UK).CrossrefGoogle Scholar
  • Cadario R, Chandon P (2020) Which healthy eating nudges work best? A meta-analysis of field experiments. Marketing Sci. 39(3):465–486.Google Scholar
  • Chan TY, Hamilton BH, Papageorge NW (2016) Health, risky behaviour and the value of medical innovation for infectious disease. Rev. Econom Stud. 83(4):1465–1510.CrossrefGoogle Scholar
  • Chatterjee C, Kubo K, Pingali V (2015) The consumer welfare implications of governmental policies and firm strategy in markets for medicines. J. Health Econom. 44(2015):255–273.CrossrefGoogle Scholar
  • Dai T, Singh S (2020) Conspicuous by its absence: Diagnostic expert testing under uncertainty. Marketing Sci. 39(3):540–563.LinkGoogle Scholar
  • Ding M, Eliashberg J (2002) Structuring the new product development pipeline. Management Sci. 48(3):343–363.LinkGoogle Scholar
  • Grennan M (2013) Price discrimination and bargaining: Empirical evidence from medical devices. Amer. Econom. Rev. 103(1):145–177.CrossrefGoogle Scholar
  • Grennan M (2014) Bargaining ability and competitive advantage: Empirical evidence from medical devices. Management Sci. 60(12):3011–3025.LinkGoogle Scholar
  • Guo T, Sriram S, Manchanda P (2020) “Let the sunshine in”: The impact of industry payment disclosure on physician prescription behavior. Marketing Sci. 39(3):516–539.LinkGoogle Scholar
  • Huang G, Khwaja A, Sudhir K (2015) Short-run needs and long-term goals: A dynamic model of thirst management. Marketing Sci. 34(5):702–721.LinkGoogle Scholar
  • Hui S, Krishnamurthy P, Kumar S, Siddegowda HB, Patel P (2020) Understanding the effectiveness of peer educator outreach on reducing sexually transmitted infections: The role of prevention vs. early detection. Marketing Sci. 39(3):500–515.Google Scholar
  • Kim T, Diwas KC (2020) The impact of hospital advertising on patient demand and health outcomes. Marketing Sci. 39(3):612–635.Google Scholar
  • Ma Y, Ailawadi KL, Grewal D (2013) Soda vs. cereal and sugar vs. fat: Drivers of healthful food intake and the impact of diabetes diagnosis. J. Marketing 77(3):101–120.CrossrefGoogle Scholar
  • Manchanda P, Honka E (2005) The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale J. Health Policy Law Ethics 5(2):Article 8.Google Scholar
  • Manchanda P, Wittink DR, Ching A, Cleanthous P, Ding M, Dong XJ, Leeflang PS, et al. (2005) Understanding firm, physician and consumer choice behavior in the pharmaceutical industry. Marketing Lett. 16(3–4):293–308.CrossrefGoogle Scholar
  • Mojir N, Sudhir K (2019) A structural model of organizational buying: Innovation adoption under share of wallet price contracts. Working paper, Harvard Business School, Boston.Google Scholar
  • Narayanan S, Manchanda P (2009) Heterogeneous learning and the targeting of marketing communication for new products. Marketing Sci. 28(3):424–441.LinkGoogle Scholar
  • Rao A (2020) Strategic research and development investment decisions in the pharmaceutical industry. Marketing Sci. 39(3):564–586.LinkGoogle Scholar
  • Shapiro B (2020) Advertising in health insurance markets. Marketing Sci. 39(3):587–611.Google Scholar
  • Stremersch S (2008) Health and marketing: The emergence of a new field of research. Internat. J. Res. Marketing 25(4):229–233.CrossrefGoogle Scholar
  • Uetake K, Yang N (2020) Inspiration from the “Biggest Loser”: Social interactions in a weight loss program. Marketing Sci. 39(3):487–499.LinkGoogle Scholar
  • Wang CJ, Ng CY, Brook RH (2020) Response to COVID-19 in Taiwan: Big data analytics, new technology, and proactive testing. JAMA 323(14):1341-1342.CrossrefGoogle Scholar
  • Wosinska M (2005) Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. 42(3):323–332.CrossrefGoogle Scholar
  • Yoon TJ (2020) Quality information disclosure and patient reallocation in the healthcare industry: Evidence from cardiac surgery report cards. Marketing Sci. 39(3):636–662.Google Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.